MDxHealth Q4 Revenues Bounce 89 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth today said that revenues in the fourth quarter increased 89 percent year over year, though its net loss widened.

For the three months ended Dec. 31, 2012, the molecular diagnostics firm took in €1.7 million ($2.2 million) in revenues, compared to €900,000 a year ago. MDxHealth attributed the improvement to its ClinicalMDx and PharmacoDx products and services, though it did not elaborate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.